Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advanced Technologies in Research, Diagnosis and Treatment of AIDS and in Oncology : : International Workshop, Naples, October 1993 / / editors, L. Chieco-Bianchi, E. Beth-Giraldo, G. Giraldo, M. Salvatore
| Advanced Technologies in Research, Diagnosis and Treatment of AIDS and in Oncology : : International Workshop, Naples, October 1993 / / editors, L. Chieco-Bianchi, E. Beth-Giraldo, G. Giraldo, M. Salvatore |
| Autore | Chieco-Bianchi L |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1994 |
| Descrizione fisica | 1 online resource (VIII + 170 pages) : : 41 figures, 2 in color, 26 tables |
| Disciplina |
615/.58 s
616.97/92 |
| Altri autori (Persone) | GiraldoG (Gaetano) |
| Collana | Issn Series |
| Soggetto topico |
Pharmacology
Infectious Diseases Oncology Pharmaceutics Immunobiology Immunology Molecular Biology Pediatrics Public Health Vaccination Virology |
| ISBN |
9783318032215
3318032212 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 978-3-8055-5970-6_Cover -- 978-3-8055-5970-6_00I -- 978-3-8055-5970-6_001 -- 978-3-8055-5970-6_005 -- 978-3-8055-5970-6_018 -- 978-3-8055-5970-6_025 -- 978-3-8055-5970-6_038 -- 978-3-8055-5970-6_048 -- 978-3-8055-5970-6_062 -- 978-3-8055-5970-6_073 -- 978-3-8055-5970-6_088 -- 978-3-8055-5970-6_102 -- 978-3-8055-5970-6_110 -- 978-3-8055-5970-6_117 -- 978-3-8055-5970-6_125 -- 978-3-8055-5970-6_134 -- 978-3-8055-5970-6_150 -- 978-3-8055-5970-6_165. |
| Record Nr. | UNINA-9910156329703321 |
Chieco-Bianchi L
|
||
| Basel : , : S. Karger, , 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Chemotherapy, Interferons and Vaccines / / D.O. White
| Antiviral Chemotherapy, Interferons and Vaccines / / D.O. White |
| Autore | White D.O |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Basel : , : S. Karger, , 1984 |
| Descrizione fisica | 1 online resource (VIII + 112 pages) : : 5 figures, 13 tables |
| Disciplina | 615/.37 |
| Collana | Issn Series |
| Soggetto topico |
Infectious Diseases
Microbiology Chemotherapy Vaccination Virology |
| ISBN |
9783318040388
331804038X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158702403321 |
|
White D.O
|
||
| Basel : , : S. Karger, , 1984 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
CDC health information for international travel [[electronic resource]] : the yellow book 2014 / / editors, Gary W. Brunette ... [et al.]
| CDC health information for international travel [[electronic resource]] : the yellow book 2014 / / editors, Gary W. Brunette ... [et al.] |
| Pubbl/distr/stampa | Oxford, England, : Oxford University Press, c2013 |
| Descrizione fisica | 1 online resource (678 p.) |
| Disciplina | 614.4202491 |
| Altri autori (Persone) | BrunetteGary W |
| Soggetto topico |
Travel - Health aspects
Vaccination Travel |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-19-998994-X
0-19-994850-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; List of Boxes, Figures, Maps, & Tables, by Topic; List of Maps; Editorial Staff; CDC Contributors; External Contributors; Acknowledgments; Preface; 1 INTRODUCTION; Introduction to Travel Health & the Yellow Book; Planning for Healthy Travel: Responsibilities & Resources; Travel Epidemiology; Travel Medicine Data Collection: GeoSentinel & Global TravEpiNet; Perspectives: The Role of the Traveler in Translocation of Disease; Perspectives: Why Guidelines Differ; 2 THE PRE-TRAVEL CONSULTATION; The Pre-Travel Consultation; Perspectives: Risks Travelers Face
Perspectives: Prioritizing Care for the Resource-Limited TravelerGeneral Recommendations for Vaccination & Immunoprophylaxis; Interactions among Travel Vaccines & Drugs; Perspectives: Fear of Vaccines; Self-Treatable Conditions; Self-Treatable Conditions; Travelers' Diarrhea; For the Record: A History of the Definition & Management of Travelers' Diarrhea; Altitude Illness; For the Record: A History of the Definition & Management of Altitude Illness; Jet Lag; Motion Sickness; Respiratory Infections; Occupational Exposure to HIV; Counseling & Advice for Travelers; Food & Water Precautions Perspectives: Prevention of Travelers' Diarrhea-It's Not Only WHAT You Eat & DrinkWater Disinfection for Travelers; Food Poisoning from Marine Toxins; Protection against Mosquitoes, Ticks, & Other Insects & Arthropods; Sunburn; Problems with Heat & Cold; Injuries & Safety; Perspectives: Terrorism; Animal-Associated Hazards; Natural Disasters & Environmental Hazards; Scuba Diving; Medical Tourism; Deep Vein Thrombosis & Pulmonary Embolism; Mental Health & Travel; Travel Health Kits; Perspectives: Pharmaceutical Quality & Counterfeit Drugs; Obtaining Health Care Abroad for the Ill Traveler Travel Insurance, Travel Health Insurance, & Medical Evacuation Insurance3 INFECTIOUS DISEASES RELATED TO TRAVEL; Amebiasis; Angiostrongyliasis, Neurologic; Anthrax; Bartonella Infections; Brucellosis; Campylobacteriosis; Chikungunya; Cholera; Coccidioidomycosis; Cryptosporidiosis; Cutaneous Larva Migrans; Cyclosporiasis; Cysticercosis; Dengue; Diphtheria; Echinococcosis; Escherichia coli; Fascioliasis; Filariasis, Lymphatic; Giardiasis; Hand, Foot, & Mouth Disease; Helicobacter pylori; Helminths, Soil-Transmitted; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis E; Histoplasmosis HIV InfectionHuman Papillomavirus; Influenza; Japanese Encephalitis; Legionellosis (Legionnaires' Disease & Pontiac Fever); Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Leptospirosis; Lyme Disease; Malaria; For the Record: A History of Malaria Chemoprophylaxis; Measles (Rubeola); Melioidosis; Meningococcal Disease; Mumps; Norovirus; Onchocerciasis (River Blindness); Pertussis; Pinworm (Enterobiasis, Oxyuriasis, Threadworm); Plague (Bubonic, Pneumonic, Septicemic); Pneumococcal Disease; Poliomyelitis; Q Fever; Rabies; Perspectives: Intradermal Rabies Preexposure Immunization Rickettsial (Spotted & Typhus Fevers) & Related Infections (Anaplasmosis & Ehrlichiosis) |
| Record Nr. | UNINA-9910452273803321 |
| Oxford, England, : Oxford University Press, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
CDC health information for international travel [[electronic resource]] : the yellow book 2014 / / editors, Gary W. Brunette ... [et al.]
| CDC health information for international travel [[electronic resource]] : the yellow book 2014 / / editors, Gary W. Brunette ... [et al.] |
| Pubbl/distr/stampa | Oxford, England, : Oxford University Press, c2013 |
| Descrizione fisica | 1 online resource (678 p.) |
| Disciplina | 614.4202491 |
| Altri autori (Persone) | BrunetteGary W |
| Soggetto topico |
Travel - Health aspects
Vaccination Travel |
| ISBN |
0-19-998994-X
0-19-994850-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; List of Boxes, Figures, Maps, & Tables, by Topic; List of Maps; Editorial Staff; CDC Contributors; External Contributors; Acknowledgments; Preface; 1 INTRODUCTION; Introduction to Travel Health & the Yellow Book; Planning for Healthy Travel: Responsibilities & Resources; Travel Epidemiology; Travel Medicine Data Collection: GeoSentinel & Global TravEpiNet; Perspectives: The Role of the Traveler in Translocation of Disease; Perspectives: Why Guidelines Differ; 2 THE PRE-TRAVEL CONSULTATION; The Pre-Travel Consultation; Perspectives: Risks Travelers Face
Perspectives: Prioritizing Care for the Resource-Limited TravelerGeneral Recommendations for Vaccination & Immunoprophylaxis; Interactions among Travel Vaccines & Drugs; Perspectives: Fear of Vaccines; Self-Treatable Conditions; Self-Treatable Conditions; Travelers' Diarrhea; For the Record: A History of the Definition & Management of Travelers' Diarrhea; Altitude Illness; For the Record: A History of the Definition & Management of Altitude Illness; Jet Lag; Motion Sickness; Respiratory Infections; Occupational Exposure to HIV; Counseling & Advice for Travelers; Food & Water Precautions Perspectives: Prevention of Travelers' Diarrhea-It's Not Only WHAT You Eat & DrinkWater Disinfection for Travelers; Food Poisoning from Marine Toxins; Protection against Mosquitoes, Ticks, & Other Insects & Arthropods; Sunburn; Problems with Heat & Cold; Injuries & Safety; Perspectives: Terrorism; Animal-Associated Hazards; Natural Disasters & Environmental Hazards; Scuba Diving; Medical Tourism; Deep Vein Thrombosis & Pulmonary Embolism; Mental Health & Travel; Travel Health Kits; Perspectives: Pharmaceutical Quality & Counterfeit Drugs; Obtaining Health Care Abroad for the Ill Traveler Travel Insurance, Travel Health Insurance, & Medical Evacuation Insurance3 INFECTIOUS DISEASES RELATED TO TRAVEL; Amebiasis; Angiostrongyliasis, Neurologic; Anthrax; Bartonella Infections; Brucellosis; Campylobacteriosis; Chikungunya; Cholera; Coccidioidomycosis; Cryptosporidiosis; Cutaneous Larva Migrans; Cyclosporiasis; Cysticercosis; Dengue; Diphtheria; Echinococcosis; Escherichia coli; Fascioliasis; Filariasis, Lymphatic; Giardiasis; Hand, Foot, & Mouth Disease; Helicobacter pylori; Helminths, Soil-Transmitted; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis E; Histoplasmosis HIV InfectionHuman Papillomavirus; Influenza; Japanese Encephalitis; Legionellosis (Legionnaires' Disease & Pontiac Fever); Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Leptospirosis; Lyme Disease; Malaria; For the Record: A History of Malaria Chemoprophylaxis; Measles (Rubeola); Melioidosis; Meningococcal Disease; Mumps; Norovirus; Onchocerciasis (River Blindness); Pertussis; Pinworm (Enterobiasis, Oxyuriasis, Threadworm); Plague (Bubonic, Pneumonic, Septicemic); Pneumococcal Disease; Poliomyelitis; Q Fever; Rabies; Perspectives: Intradermal Rabies Preexposure Immunization Rickettsial (Spotted & Typhus Fevers) & Related Infections (Anaplasmosis & Ehrlichiosis) |
| Record Nr. | UNINA-9910779881703321 |
| Oxford, England, : Oxford University Press, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
CDC Health Information for International Travel 2012 [[electronic resource]]
| CDC Health Information for International Travel 2012 [[electronic resource]] |
| Autore | CDC |
| Pubbl/distr/stampa | Oxford University Press, USA, 2011 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 613.68 |
| Altri autori (Persone) | BrunetteGary W |
| Soggetto topico |
Communicable Disease Control
Travel -- Health aspects Travel Vaccination Public Health Health & Biological Sciences Public Health - General |
| ISBN |
0-19-983165-3
0-19-983036-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; List of Boxes, Figures, Maps, & Tables, by Topic; List of Maps; Editorial Staff; CDC Contributors; External Contributors; Acknowledgments; Preface; 1 INTRODUCTION; Introduction to Travel Health & the Yellow Book; Planning for Healthy Travel: Responsibilities & Resources; Travel Epidemiology; Perspectives: The Role of the Traveler in Translocation of Disease; Perspectives: Risks Travelers Face; Perspectives: Why Guidelines Differ; 2 THE PRE-TRAVEL CONSULTATION; The Pre-Travel Consultation; General Recommendations for Vaccination & Immunoprophylaxis
Perspectives: Vaccine Recommendations of the ACIPDrug-Vaccine & Drug-Drug Interactions; Perspectives: Fear of Vaccines; Self-Treatable Conditions; Self-Treatable Conditions; Travelers' Diarrhea; Altitude Illness; Jet Lag; Motion Sickness; Respiratory Infections; Occupational Exposure to HIV; Counseling & Advice for Travelers; Food & Water Precautions; Perspectives: Prevention of Travelers' Diarrhea-It's Not Only WHAT You Eat & Drink; Water Disinfection for Travelers; Food Poisoning from Marine Toxins; Protection against Mosquitoes, Ticks, & Other Insects & Arthropods; Sunburn Problems with Heat & ColdInjuries & Safety; Animal-Associated Hazards; Natural Disasters & Environmental Hazards; Scuba Diving; Medical Tourism; Deep Vein Thrombosis & Pulmonary Embolism; Mental Health & Travel; Travel Health Kits; Perspectives: Counterfeit Drugs; Obtaining Health Care Abroad for the Ill Traveler; Travel Health Insurance & Evacuation Insurance; 3 INFECTIOUS DISEASES RELATED TO TRAVEL; Amebiasis; Angiostrongyliasis (Angiostrongylus cantonensis Infection, Neurologic Angiostrongyliasis); Anthrax; Bartonella-Associated Infections; Brucellosis; Campylobacter Enteritis; Chikungunya CholeraCoccidioidomycosis; Cryptosporidiosis; Cutaneous Larva Migrans; Cyclosporiasis; Cysticercosis; Dengue Fever & Dengue Hemorrhagic Fever; Diphtheria; Echinococcosis; Filariasis, Lymphatic; Giardiasis; Helicobacter pylori; Helminths, Intestinal; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis E; Histoplasmosis; HIV & AIDS; Human Papillomavirus; Influenza (Seasonal, Zoonotic, & Pandemic); Japanese Encephalitis; Legionellosis (Legionnaires' Disease & Pontiac Fever); Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Leptospirosis; Lyme Disease; Malaria; Measles (Rubeola); Melioidosis Meningococcal DiseaseMumps; Norovirus; Onchocerciasis (River Blindness); Pertussis; Pinworm (Enterobiasis, Oxyuriasis, Threadworm); Plague (Bubonic, Pneumonic, Septicemic); Pneumococcal Disease (Streptococcus pneumoniae); Poliomyelitis; Q Fever; Rabies; Rickettsial (Spotted & Typhus Fevers) & Related Infections (Anaplasmosis & Ehrlichiosis); Rubella; Scabies (Sarcoptic Itch, Sarcoptic Acariasis); Schistosomiasis; Sexually Transmitted Diseases; Perspectives: Sex Tourism; Shigellosis; Smallpox & Other Orthopoxvirus-Associated Infections; Strongyloidiasis; Taeniasis; Tetanus Tickborne Encephalitis |
| Record Nr. | UNINA-9910791213303321 |
|
CDC
|
||
| Oxford University Press, USA, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The children's vaccine initiative : achieving the vision / / Violaine S. Mitchell, Nalini M. Philipose, and Jay P. Sanford, editors ; Committee on the Children's Vaccine Initiative : Planning Alternative Strategies Toward Full U.S. Participation, Division of International Health, Institute of Medicine
| The children's vaccine initiative : achieving the vision / / Violaine S. Mitchell, Nalini M. Philipose, and Jay P. Sanford, editors ; Committee on the Children's Vaccine Initiative : Planning Alternative Strategies Toward Full U.S. Participation, Division of International Health, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1993 |
| Descrizione fisica | 1 online resource (xiii, 221 pages) : illustrations |
| Disciplina | 614.4/7/083 |
| Altri autori (Persone) |
SanfordJay P. <1928->
MitchellViolaine S PhiliposeNalini M |
| Soggetto topico |
Vaccination of children
Vaccines Immunization of children Vaccination Children Infants Immunization Programs Child Immunization Schedule Infant |
| ISBN |
9786610196012
9781280196010 1280196017 9780309585835 030958583X 9780585143521 0585143528 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Children's Vaccine Initiative -- Copyright -- Preface -- Acknowledgments -- Contents -- 1 Executive Summary -- THE CHILDREN'S VACCINE INITIATIVE -- THE INSTITUTE OF MEDICINE REPORT -- COMMITTEE FINDINGS -- Resources and Infrastructure -- Vaccine Demand and Supply -- Demand -- Supply -- Innovation -- Investing in New and Improved Vaccines -- Stages of Vaccine Development -- Pilot Production -- Clinical Trials -- Scaleup and Large-Scale Manufacture -- Technology Transfer -- A STRATEGY TO ENHANCE U.S. PARTICIPATION -- NOTE -- REFERENCE -- 2 Why a Children's Vaccine Initiative? -- PROGRESS TOWARD UNIVERSAL CHILDHOOD IMMUNIZATION -- Limits of the Expanded Program on Immunization -- THE CHILDREN'S VACCINE INITIATIVE -- Characteristics of CVI Vaccines -- Vaccines Should Be Single Dose -- Vaccines Should Be Administered Near Birth -- Vaccines Should Be Combined in Novel Ways -- Vaccines Should Be Heat Stable -- Vaccines Should Be Effective Against Additional Diseases -- Vaccines Should Be Affordable -- Concerns About the CVI -- RELEVANCE OF THE CVI TO U.S. IMMUNIZATION EFFORTS -- Status of Immunization Efforts in the United States -- A Role for the CVI in the United States -- REFERENCES -- 3 Resources and Infrastructure -- RESOURCES IN THE UNITED STATES -- U.S. Federal Agencies and Programs -- U.S. Agency for International Development -- Center for Biologics Evaluation and Research, U.S. Food and Drug Administration -- Centers for Disease Control and Prevention -- U.S. Department of Defense -- National Institutes of Health -- National Vaccine Program -- Other Federal Programs -- U.S. State Vaccine Manufacturers -- Massachusetts -- Michigan -- U.S.-Based Pharmaceutical Firms -- Connaught Laboratories, Inc. -- Lederle-Proxis Biologicals -- Merck & -- Co., Inc. -- SmithKline Beecham -- Wyeth-Ayerst -- Development-Stage Companies.
North American Vaccine -- MedImmune -- Univax Biologics, Inc. -- Nongovernmental Organizations -- The Children's Defense Fund -- March of Dimes Birth Defects Foundation -- Rockefeller Foundation -- Rotary Foundation -- INTERNATIONAL RESOURCES -- Multilateral Organizations -- Pan American Health Organization -- PAHO Revolving Fund -- SIREVA Project -- United Nations Development Program -- United Nations Children's Fund -- Vaccine Independence Initiative -- World Bank -- World Health Organization -- Expanded Program on Immunization -- Program for Vaccine Development -- Children's Vaccine Initiative -- Public-Sector Resources -- Private-Sector Resources -- Nongovernmental Organizations -- Task Force for Child Survival and Development -- Save the Children Fund -- REFERENCES -- 4 Vaccine Demand and Supply -- GLOBAL DEMAND AND SUPPLY -- Demand -- Regional Demand -- Supply -- Procurement -- Innovation -- DEMAND AND SUPPLY IN THE UNITED STATES -- Demand -- Supply -- Pricing -- Vaccine Innovation -- NOTE -- REFERENCES -- 5 Investing in New and Improved Vaccines -- MARKET CONSIDERATIONS -- Market Size -- Intellectual Property -- Patent Rights and Limitations -- Patents and Vaccines -- Infringement -- LIABILITY -- REFERENCES -- 6 Stages of Vaccine Development -- PRIORITY SETTING -- BASIC AND APPLIED RESEARCH -- CLINICAL EVALUATION -- LICENSURE -- PRODUCTION -- Pilot Production -- ScaleUp and Full-Scale Manufacture -- Vaccine Production in Developing Countries -- RECOMMENDATIONS FOR USE -- PROCUREMENT -- DISTRIBUTION AND DELIVERY -- SURVEILLANCE -- Immunization Status -- Monitoring Effectiveness of Vaccines -- Adverse Reactions -- Setting Priorities for Vaccine Use and New Vaccines -- REFERENCES -- 7 A Strategy to Enhance U.S. Participation in the Children's Vaccine Initiative -- A NATIONAL VACCINE AUTHORITY -- Mission -- Functions. Setting Priorities and Product Characterization -- Basic Research -- Applied Research and Exploratory Development -- Intellectual Property Rights -- Product Development -- Clinical Evaluation -- Regulation -- Manufacture -- Procurement -- Monitoring and Evaluation -- Management and Organization -- Funding -- Location -- Points to Consider for Locating the CVI in an Existing Federal Agency -- Options -- U.S. Agency for International Development -- Centers for Disease Control and Prevention -- U.S. Department of Defense -- U.S. Food and Drug Administration -- National Institutes of Health -- The National Vaccine Program -- Independent Organization -- NOTE -- REFERENCES -- Appendixes -- A Relevant Intellectual Property Rights Law -- PATENTS -- Rights and Limitations -- Infringement -- Potential Barriers and Incentives -- First-to-File Versus First-to-Invent -- Backlog in the Patent and Trademark Office -- Costs -- Disclosure to Government Agencies -- Relevant Legislation and Terminology -- Drug Price Competition and Patent Term Restoration Act of 1984 (P.L. 98-417) -- Omnibus Trade and Competitiveness Act (P.L. 100-418) -- Grace Period -- Orphan Drug Act of 1983 (P.L. 99-91) -- Patent and Trademark Amendments of 1980 (P.L 96-517) -- Experimental Use Exception -- TRADE SECRETS (KNOW-HOW) -- Definition -- Confidentiality -- Rights of the Trade Secret Owner -- Rights Against Individuals in Privity -- Protection by Contract -- Implied Contract/Special Relationships -- Rights Against Third Parties -- Additional Rights of a Trade Secret Owner -- Rights to Use Another's Trade Secrets -- REFERENCES -- B National Vaccine Injury Compensation Program -- DEFINITION AND PURPOSE -- BACKGROUND -- FILING A CLAIM UNDER NVICP -- KEY CHARACTERISTICS -- REFERENCES -- C Regulatory Aspects of Vaccine Development, Manufacture, and Distribution -- THE LICENSURE PROCESS. POSTLICENSING -- Manufacture -- Distribution -- THE DRUG EXPORT AMENDMENTS ACT OF 1986 -- REFERENCES -- D Strategies for Achieving Full U.S. Participation in the Children's Vaccine Initiative -- STRATEGY 1: RETAIN THE CURRENT SYSTEM -- Option 1: Increased Funding for CVI Vaccine Research -- Contribution to the Global CVI -- Option 2: Purchase Existing Vaccines -- Contribution to the Global CVI -- Option 3: Improve Vaccine Delivery -- Contribution to the Global CVI -- STRATEGY 2: FORGING NEW PARTNERSHIPS BETWEEN THE PUBLIC AND PRIVATE SECTORS -- Option 1: Broker CVI R& -- D and Pilot Manufacture -- Contribution to the Global CVI -- Option 2: Develop an Entity with CVI-Related R& -- D and Pilot Manufacturing Capabilities -- Contribution to the Global CVI -- STRATEGY 3: EMBARK ON A PUBLIC-SECTOR MODEL -- Contribution to the Global CVI -- E Public Health Service Act (1944) -- PUBLIC LAWS-CH. 373-JULY 1, 1944 PART F-BIOLOGICAL PRODUCTS Regulation of Biological Products -- Interference With Officers -- Penalties for Offenses -- F National Vaccine Program Legislation -- TITLE XXI-VACCINES SUBTITLE 1-NATIONAL VACCINE PROGRAM -- Establishment -- Program Responsibilities -- Plan -- Report -- National Vaccine Advisory Committee -- Authorizations -- G Immunization Schedules -- H Historical Record of Vaccine Product License Holders in the United States -- I Working Group Participants June 11-13, 1992 -- NOTES -- J Committee and Staff Biographies -- K Acronyms. |
| Record Nr. | UNINA-9910970771503321 |
| Washington, D.C., : National Academy Press, 1993 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical and experimental vaccine research
| Clinical and experimental vaccine research |
| Pubbl/distr/stampa | Seoul, : Korean Vaccine Society |
| Soggetto topico |
Vaccines
Vaccination |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2287-366X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996321385003316 |
| Seoul, : Korean Vaccine Society | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Clinical and experimental vaccine research
| Clinical and experimental vaccine research |
| Pubbl/distr/stampa | Seoul, : Korean Vaccine Society |
| Soggetto topico |
Vaccines
Vaccination |
| Soggetto genere / forma |
Periodicals.
Periodical |
| ISSN | 2287-366X |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910139067003321 |
| Seoul, : Korean Vaccine Society | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Como Se Comunicar Sobre a Segurança das Vacinas : Diretrizes para Orientar Os Trabalhadores Da Saúde Quanto à Comunicação Com Pais, Mães, Cuidadores e Pacientes
| Como Se Comunicar Sobre a Segurança das Vacinas : Diretrizes para Orientar Os Trabalhadores Da Saúde Quanto à Comunicação Com Pais, Mães, Cuidadores e Pacientes |
| Autore | Organization Pan American Health |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D. C. : , : Pan American Health Organization (PAHO), , 2021 |
| Descrizione fisica | 1 online resource (64 pages) |
| Soggetto topico |
Vaccination
Communication in medicine |
| ISBN |
9789275722824
927572282X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | por |
| Altri titoli varianti | Como Se Comunicar Sobre a Segurança das Vacinas |
| Record Nr. | UNINA-9910965561703321 |
|
Organization Pan American Health
|
||
| Washington, D. C. : , : Pan American Health Organization (PAHO), , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Confronting a growing public health threat : measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019
| Confronting a growing public health threat : measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2020 |
| Descrizione fisica | 1 online resource (v, 84 pages) : illustrations |
| Soggetto topico |
Measles - United States
Communicable diseases - United States - Prevention Immunization - United States Vaccination - United States Communicable diseases - Prevention Immunization Measles Vaccination |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Confronting a Growing Public Health Threat |
| Record Nr. | UNINA-9910714768503321 |
| Washington : , : U.S. Government Publishing Office, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Vaccination
(97)
- Vaccines (29)
- Immunization (18)
- Travel - Health aspects (18)
- Communicable diseases - Prevention (10)